Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MLKL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PARP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C19orf66 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX60L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP110 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on